APA
APA Corporation
$51.66
-0.24
(-0.46%)
Mkt Cap
18.10B
Volume
6,754,290
52W Range
21.63-52.39
Sector
Energy
Beta
0.37
EPS (TTM)
4.73 USD
P/E Ratio
10.92
Revenue (TTM)
8.81B USD
Rev Growth (5Y)
+15.0%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
What we estimate one share is worth
$48.89
Overvalued
weak signal
5.7% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Oil & Gas E&P
72.4 / 100 composite
An oil & gas explorer and producer — graded A–F vs. similar companies.
Company Description
APA Corporation operates in the upstream segment of the oil and natural gas industry, utilizing its various subsidiaries to explore for, develop, and produce hydrocarbon assets. The company maintains significant operational presences in the United States, Egypt, and the United Kingdom, while also conducting exploration activities offshore Suriname. Furthermore, APA Corporation manages critical gathering, processing, and transmission infrastructure within West Texas and holds ownership interests in four major pipelines connecting the Permian Basin to the Gulf Coast. Established in 1954, the company is headquartered in Houston, Texas.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.92B | 9.74B | 8.28B | 11.07B | 7.99B | 4.43B | 6.49B | 7.35B | 5.89B | 5.37B | 6.38B | 12.79B |
| Net Income | 1.43B | 804.00M | 2.85B | 3.67B | 1.14B | (4.78B) | (3.52B) | 40.00M | 1.30B | (1.41B) | (10.35B) | (8.36B) |
| EPS | 3.99 | 2.28 | 9.27 | 11.07 | 2.60 | -12.86 | -9.43 | 0.10 | 3.42 | -3.71 | -61.19 | -14.07 |
| Free Cash Flow | 1.78B | 769.00M | 772.00M | 2.54B | 2.39B | 114.00M | (94.00M) | (127.00M) | (332.00M) | 481.00M | (2.14B) | (3.01B) |
| FCF / Share | 4.96 | 2.18 | 2.51 | 7.67 | 6.38 | 0.30 | -0.25 | -0.33 | -0.87 | 1.27 | -5.66 | -7.83 |
| Operating CF | 4.54B | 3.62B | 3.13B | 4.94B | 3.50B | 1.39B | 2.87B | 3.78B | 2.43B | 2.43B | 2.67B | 7.96B |
| Total Assets | 19.00B | 19.39B | 15.24B | 13.15B | 13.30B | 12.75B | 18.11B | 21.58B | 21.92B | 22.52B | 25.50B | 55.95B |
| Total Debt | 4.81B | 6.16B | 5.30B | 5.62B | 7.61B | 8.89B | 8.73B | 8.20B | 8.48B | 8.54B | 8.72B | 11.24B |
| Cash & Equiv | 516.00M | 625.00M | 87.00M | 245.00M | 302.00M | 262.00M | 247.00M | 714.00M | 1.67B | 1.38B | 1.47B | 769.00M |
| Book Value | 6.09B | 5.28B | 2.65B | 423.00M | (1.59B) | (1.64B) | 3.25B | 7.13B | 7.42B | 6.24B | 7.89B | 25.94B |
| Return on Equity | 0.24 | 0.15 | 1.08 | 8.69 | N/A | N/A | -1.08 | 0.01 | 0.18 | -0.23 | -1.31 | -0.32 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.37B | 2.33B | 1.99B | 2.12B | 2.18B | 2.64B | 2.71B | 2.53B | 2.54B | 1.95B | 2.17B | 2.31B |
| Net Income | 747.00M | 446.00M | 279.00M | 205.00M | 603.00M | 347.00M | 354.00M | (223.00M) | 541.00M | 132.00M | 1.77B | 459.00M |
| EPS | 2.11 | 1.26 | 0.79 | 0.57 | 1.67 | 0.95 | 0.96 | -0.60 | 1.46 | 0.44 | 5.79 | 1.49 |
| Free Cash Flow | 1.14B | 12.00M | 218.00M | 741.00M | 514.00M | 306.00M | 342.00M | 472.00M | 121.00M | (162.00M) | 455.00M | 135.00M |
| FCF / Share | 3.22 | 0.03 | 0.61 | 2.05 | 1.42 | 0.84 | 0.93 | 1.28 | 0.33 | -0.54 | 1.49 | 0.44 |
| Operating CF | 1.71B | 554.00M | 808.00M | 1.46B | 1.18B | 1.10B | 1.04B | 1.34B | 877.00M | 368.00M | 1.03B | 764.00M |
| Total Assets | 17.97B | 18.08B | 19.00B | 17.70B | 18.08B | 18.53B | 19.39B | 19.38B | 20.20B | 14.95B | 15.24B | 13.54B |
| Total Debt | 3.88B | 4.54B | 4.81B | 4.59B | 4.66B | 5.49B | 6.16B | 6.47B | 6.85B | 5.30B | 5.30B | 5.69B |
| Cash & Equiv | 444.00M | 293.00M | 516.00M | 475.00M | 107.00M | 67.00M | 625.00M | 64.00M | 160.00M | 102.00M | 87.00M | 95.00M |
| Book Value | 7.02B | 6.46B | 6.09B | 5.96B | 5.91B | 5.44B | 5.28B | 5.11B | 5.42B | 2.61B | 2.65B | 1.08B |
| Return on Equity | 0.11 | 0.07 | 0.05 | 0.03 | 0.10 | 0.06 | 0.07 | -0.04 | 0.10 | 0.05 | 0.67 | 0.43 |
APA News
Are Investors Undervaluing APA (APA) Right Now?
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
APA Corporation $APA Holdings Raised by IFP Advisors Inc
APA Plans to Keep Forties Charlie Operational Amid Strike Threat
Oil Prices Climb: 3 Energy Stocks Poised to Benefit From the Rally
APA Group Stapled Securities (APAJF) Shareholder/Analyst Call Transcript
APA Group commits $700 million to Bulloo pipeline to boost southern gas supply
APA (APA) Surpasses Market Returns: Some Facts Worth Knowing
Earnings Estimates Rising for APA (APA): Will It Gain?
APA (APA) is a Great Momentum Stock: Should You Buy?